JOURNAL OF Vol. 268, No. 16, of June 5, pp. 11742-11749 ... · THE JOURNAL OF BIOLOGICAL CHEMISTRY 0 1993 by The American Society for Biochemistry and Molecular Biology, Inc Vol.

THE JOURNAL OF BIOLOGICAL CHEMISTRY 0 1993 by The American Society for Biochemistry and Molecular Biology, Inc Vol. 268, No. 16, Issue of June 5, pp. 11742-11749,1993

Printed in U S A .

The ,8 Isoform of Protein Kinase C Stimulates Human Melanogenesis by Activating Tyrosinase in Pigment Cells*

(Received for publication, July 22, 1992, and in revised form, January 25, 1993)

Hee-Young Park#& Vladimir RussakovskyS, Shigeo OhnoY, and Barbara A. GilchrestS From the $Department of Dermtology, Boston University School of Medicine, Boston, Massachusetts 02118 and lTDepartment of Molecular Biology, School of Medicine, Yokohumu City University, 3-9 Fuku-ura, Kanazawa-Ku, Yokohama 236, Japan

We have investigated the role of protein kinase C (PKC) in human melanogenesis. The level of PKC activity paralleled the total melanin content in cultured newborn melanocytes. Activation of PKC by treatment with 6 X 10“ M phorbol dibutyrate acutely caused a doubling in the activity of tyrosinase, the rate-limiting enzyme in melanogenesis, known to correlate directly with melanin synthesis in these cells. When PKC was depleted to 6-10% of initial levels, there was a 40- 60% parallel reduction in tyrosinase activity; and regeneration of PKC activity was associated with the recovery of tyrosinase activity. By Northern blot analysis, the a and 8 but not the y isoforms were detectable in melanocytes. By Western blot analysis, the racially determined pigment level in cultured melanocytes correlated with PKC-8 protein expression. In a pigmented human melanoma line (P-MM4,20-30 ng melaninlpg protein) and its nonpigmented subclone (NP-”4, undetectable melanin), PKC-a mRNA was expressed in both, whereas PKC-8 mRNA was detectable only in P-MM4 cells. Tyrosinase protein level was comparable in both cell lines. When NP-MM4 cell lysate was incubated with melanocyte lysate known to contain PKC-8, tyrosinase activity per pg of melanocyte protein in the combined lysate increased, consistent with activation of the previously inactive tyrosinase of NP-MM4 origin. Moreover, NP-MM4 cells transiently transfected with PKC-8 cDNA increased tyrosinase activity from undetectable to detectable levels. These combined data show that PKC-8 regulates human melanogenesis by activating tyrosinase.

Protein kinase C (PKC)’ is a calcium- and phospholipid- dependent protein kinase activated by diacylglycerol, a minor lipid species generated when polypeptide growth factors bind to their cell surface receptors, and by tumor promoting phor- bo1 esters (1, 2). PKC has been implicated in a wide range of biological functions including cell proliferation (3), malignant transformation (4-6), and regulation of proto-oncogenes (7- 9). PKC acts in part by phosphorylating proteins such as the epidermal growth factor receptor (lo), the insulin receptor

* This work was supported in part by National Institutes of Health Grant HD 24538 (to B. A. G.) and by a Dermatology Foundation Grant (to H. Y . P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed. Tel.: 617-638- 5527; Fax: 617-638-5515.

The abbreviations used are: PKC, protein kinase C; PDBu, phor- bo1 dibutyrate; PBS, phosphate-buffered saline; TPA, 12-0-tetradecanoylphorbol-13-acetate; kb, kilobase pairs.

( l l) , the protein product of the ras oncogene (12), and other intracellular substrates (13, 14).

Molecular cloning of PKC revealed that PKC is a multigene family with at least ten isoforms (reviewed in Ref. 15) that are expressed differentially among tissues. Of the better stud- ied isoforms, PKC-a is found ubiquitously, but PKC-@ is found only in some tissues, and PKC--y appears virtually restricted to brain tissues (reviewed in Ref. 16), suggesting possible functional differences among them.

Recent results further support the postulation that different PKC isoforms have different cellular functions. The t isoform of PKC, but not the a isoform, has been shown to be preferentially activated in response to interferon-a in Daudi cells (17). NIH 3T3 cells transfected with PKC-7 grew to a higher density and showed increased tumorigenicity when inoculated into nude mice (4). The @ isoform was reported to regulate phospholipid hydrolysis by regulating phospholipase D activity (18). The @ isoform was further implicated in cell growth stimulation in that transfected cells overexpressing PKC-@ grew to a higher density, showed anchorage independence (5), and were more susceptible to transformation by activated H- ras oncogene (6). In contrast, overexpression of PKC-P in HT29 human colon cancer cells reduced growth and was tumor-suppressive in these cells (19). Thus, the role of PKC isoforms appear to depend partly on the cell type.

Recently, our laboratory reported that diacylglycerol induces human melanogenesis in cultured human melanocytes (20), suggesting that PKC may also be involved in this differentiated function of melanocytes. We now report that the @ isoform of PKC specifically regulates human melanogenesis.

EXPERIMENTAL PROCEDURES

Materials-Dulbecco’s modified essential medium, L15, nonessen- tial amino acids, glutamine, medium 199, and trypsin were purchased from GIBCO. Recombinant basic fibroblast growth factor was purchased from Amgen, triiodothyronine from Collaborative Research, and hydrocortisone from Calbiochem. Phorbol dibutyrate, insulin, transferrin, and synthetic melanin were from Sigma. Choleragen was from List Biologicals. Nylon membrane was from Amersham Corp. PKC antibodies were from Seigakagu International. Bovine calf serum and fetal calf serum were from HyClone Laboratories, Inc. All radiolabeled nucleotides were purchased from Du Pont-New England Nuclear. The oligolabeling kit was purchased from Pharmacia LKB Biotechpology Inc. Lipofectin reagent was from Life Technologies, Inc.

Cells and Media-Neonatal foreskins obtained within 2 h of elec- tive circumcision were used to culture human melanocytes as previously described (21). In brief, the epidermis was separated from the dermis after overnight incubation in 0.25% trypsin at 4 “c. Primary cultures were then established in medium 199 supplemented with

M triiodothyronine, 10 rg/ml transferrin, 10 pg/ml insulin, 1.4 x M hydrocortisone, IO-’ M choleragen, 10 ng/ml basic fibroblast growth factor, and 5-10% fetal bovine serum; all post primary cultures were maintained in a low calcium (0.03 mM) version of this medium known to selectively support melanocyte growth (21, 22).

11742

PKC-p in Human Melanogenesis 11743

As previously reported (21), the cultures reflected the racially determined pigment level in that melanocytes cultured from black donors routinely showed higher levels of melanin than melanocytes from white donors, often by a factor of 10-fold or more. Cells a t first to third passages were routinely used. From the primary cultures to the third passage, there was no apparent change in melanin content, as observed by light microscopy.

The MM4 human melanoma cells were obtained from Dr. U. Stierner, Gotenborg, Sweden, and maintained in Dulbecco's modified essential medium (55%), L15 (27%), fetal bovine serum (15%), non- essential amino acids, 1% glutamine (2 mM), and insulin (10 pg/ml) (22).

Melanin Content of Cells-1 X 10' cells were routinely used to measure melanin content. Cells were spun at 2,500 rpm for 15 min, and the resultingpellet was dissolved in 0.5 ml of 1 N NaOH. Melanin concentration was calculated by OD175 and comparison with a standard curve of synthetic melanin, as previously described (20). Melanin levels above 5 ng/pg protein were reliably detectable. Protein concentration was determined by Bradford (23) assay using bovine serum albumin as a standard.

Northern Blot Analysis-Total cellular RNA was isolated by the method of Chirgwin et al. (24). Routinely, 20 pg of total cellular RNA/ lane were size-fractionated through a 1% agarose gel containing 2.2 M formaldehyde. The RNA was then transferred to a Hybond-N nylon membrane and immobilized by short ultraviolet light illumination. Blots were prehybridized for 4-24 h, hybridized with labeled specific probes, and washed according to Park and Campisi (25).

Probes-The cDNA probe for human tyrosinase (Pmel 34) was a generous gift from B. Kwon (Guthrie Research Institute, Sayre, PA) (26). cDNA for glyceraldehyde-3-phosphate dehydrogenase was generated using the polymerase chain reaction (27). cDNAprobes specific

Type Cell Culture. cDNAs were radiolabeled with [32P]dCTP, using for PKC a, @, and y isoforms were purchased from the American

a commercial oligolabeling kit. Protein Kinase C Actiuity-Soluble cell lysates, containing both

cytosolic- and membrane-associated PKC, were prepared as previously described (25). In brief, lysates were clarified by centrifugation at 100,000 X g for 60 min, and 500 pl of the supernatant, equivalent to 0.5-10 X lo6 cells, were mixed with 1.0 ml of DEAE-52 cellulose resin which had been equilibrated with washing buffer consisting of 20 mM Tris (pH 7.5), 2 mM EDTA, 0.5 mM EGTA, and 1 mM dithiothreitol. The resin and the lysate were allowed to react for 2-3 min and washed three times with washing buffer (5 ml each wash). Bound PKC was eluted from the resin by two successive washes with washing buffer containing 100 mM NaCl.

To measure cytosolic and membrane-associated PKC, cells were homogenized (20 strokes) in lysis buffer devoid of Triton X-100. Membrane fraction was separated from cytosol by centrifugation of homogenized lysate at 100,000 cpm for 60 min at 4 "C. PKC was extracted from the resulting pellet by incubating with lysis buffer containing 1% Triton X-100 for 60 min at 4 "C. Cytosolic and membrane-associated PKC was subjected to partial purification using DEAE-52 resin.

Calcium- and phospholipid-stimulated PKC activity was determined using 50 pl eluent (2-5 pg protein), phosphatidylserine, and phorbol dibutyrate (PDBu) to activate PKC, and histone type 111-S as substrate, as previously described (25). A 10-min incubation at 37 "C was routinely used. For each determination, a control reaction was performed in the absence of phosphatidylserine and PDBu. Activity was expressed as counts jmin of incorporated radioactivity/ pg protein/min in the presence of phosphatidylserine and PDBu, minus the radioactivity incorporated in the absence of radioactivity phosphatidylserine and PDBu (background kinase activity). The background was generally less than 5-10% of the total incorporated radioactivity.

Western Blotting-Immunoblot analysis was performed for PKC according to Park and Campisi (25) and for tyrosinase as described by Jimenez et al. (28). For PKC, cell lysate was partially purified for PKC, and 50-100 pg of partially purified protein were routinely used. Lysate enriched for tyrosinase was prepared as described under "Tyrosinase Activity," and 20-50 pg of protein were used. Protein samples were subjected to 7.5% sodium dodecyl sulfate-polyacrylamide gel electrophoresis, as described by Laemmli (29), and transferred to a nitrocellulose membrane electrophoretically. The membrane was preincubated in 100% Blotto (5 g of nonfat dry milk in 100 ml of phosphate-buffered saline (PBS)) for 3 h a t room temperature with shaking, followed by an overnight incubation with antiserum (0.5-1 pg/ml in 10% Blotto) a t 4 "C. At the end of the incubation,

the membrane was washed extensively with PBS containing 0.5% Tween 20, then 1251-protein A (2-5 X 10' cpm/ml in 5% bovine serum albumin in PBS) was added, and the incubation was continued for 1 h at room temperature. The membrane was washed extensively in PBS containing 0.5% Tween 20, dried, and exposed to preflashed Kodak X-Omat film.

Tyrosinase Actiuity-Tyrosinase activity was measured according to Pomerantz et al. (30). In brief, 5 x lo5 cells were briefly sonicated in 80 mM PO!- (pH 6.8) containing 1% Triton X-100, and tyrosinase was extracted for 60 min at 4 " C . 10-50 ug of cellular protein were incubated with 250 nM L-tyrosine, 25 nM t-deoxyphenylalanine, 12.5 pg of chloramphenicol, and 5 pCi of ~-[3,5-~H]tyrosine for 30-60 min at 37 "C. The reaction was stopped by addition of 500 p1 of 10% trichloroacetic acid containing 0.2% BSA. Trichloroacetic acid-soluble material was reacted with Norit A, and released 3H20 was measured using a scintillation counter. The activity was expressed as counts/min 3H20 released/pg protein/h minus the nonspecific incor- poration of radioactivity, determined by using lysate boiled for 30 min (background). Background was generally less than 5-10% of the sample.

Transient Transfections-1 x 10' NP-MM4 cells were plated in 60-mm dishes 24 h prior to introducing PKC-0 cDNA. PKC-@ cDNA was cloned into an expression vector containing by SRa promotor system, which is composed of the Simian virus 40 early promotor and the R segment and part of the U5 sequence (R-U5') of the long terminal repeat of human T cell leukemia virus type I (31). 6-10 pg of PKC-0 cDNA and 20 pl of lipofectin reagent, a 1:l liposome formulation of the cationic lipid N-[(-2,3-dioleoyloxy)propyl]n,n,n- trimethylammonium chloride and dioleoyl phosphotidylethanolamine in membrane-filtered water, were incubated at room temperature for 20-25 min and introduced onto cells. Transfection mixture was removed after 6-10 h, and cultures were provided standard NP-MM4 medium. After 48-72 h, cells were harvested and tyrosinase activity was measured. cDNA containing mutated inactive PKC was used as a control.

Immunoprecipitation of PKC-1 X lo6 NP-MM4 cells were plated in 100-mm dishes. When cells were grown to near confluency, soluble cellular lysates, containing both cytosolic and membrane-associated PKC, was prepared as described under "Protein Kinase C Activity." 300-500 pg of lysate protein were incubated in 5 pg of either antibody against &tubulin or PKC-,5' for 2 h at 37 "C, then further incubated with 100 pl of protein A-Shepharose for 1 h at room temperature. Samples were spun and supernatant was used for the tyrosinase experiment. Remaining pellet was subjected to 7.5% sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and immunoblot was performed using an antibody against PKC-@. There was no detectable level of PKC-0.

RESULTS

Correlation of Total PKC Activity and Melanin Content- To investigate the possible role of PKC in human melanogenesis, we initially determined whether total melanin content correlates with total activatable PKC. Melanocytes were cultured under standard conditions to near confluency and total PKC activity and melanin content were measured in paired cultures. In experiments comparing four donors, PKC activity was 1,450, 1,300, 813, and 613 cpmlyg protein, and melanin content was 95, 65, 25, and 16 ng/Hg protein, respectively, indicating a moderate correlation in these measurements among individual cultures (Fig. lA). Because these cells are known to be actively melanogenic under the basal conditions (20), if PKC is involved in melanogenesis, then part of the PKC should be in an active form. Because membrane-associated PKC is considered to be active (32-34), we determined cytoplasmic uersus membrane-associated PKC activity (Fig. 1B). Approximately 30-50% of total PKC activity was associated with the membrane in all four donors, suggesting an endogenously active form of PKC, consistent with a role for PKC in human melanogenesis. The endogenous agent activating up to half the total PKC in melanocytes under basal condition is unknown, although these cells are known to respond to diacylglycerol (20) which may be continuously produced in sufficient amounts.

11744 PKC-/3 in Human Mehnogenesis

I’KC 0 Melanin

T

measured.

Tyrosinase Activity after Acute and Chronic Exposure of Melanocytes to Phorbol Dibutyrate-It is known that acute exposure of cells to phorbol esters activate PKC and chronic treatment down-regulates and depletes PKC (32-34). To determine whether activation of PKC increases melanogenic activity and depletion of PKC reduces melanogenic activity, cultured human melanocytes were treated with 5 X M PDBu for 30 min, 2 h, 4 h, and up to 3 days, and total activatable PKC and tyrosinase activity were then measured. Tyrosinase activity, known to correlate directly with melanin synthesis rates (35), was measured because it is a more sen- sitive indicator of changes in melanin synthesis rate than melanin content that reflects the balance between past melanin synthesis rates and cell division rates. As expected, treatment of melanocytes with PDBu caused initial activation of PKC by translocation of PKC from cytosol to membrane, maximal at 30 min to 2 h, followed by a 95% loss of PKC activity within 24 h (Fig. 2 A ) . In parallel, tyrosinase activity was also increased from 3200 to 5700 cpm/pg/h by 2 h and then was reduced to 1500 cpm/pg/h compared to untreated cells within 24 h (Fig. 2B). Three-day exposure to PDBu caused a further reduction to 1000 cpm/pg/h in tyrosinase activity. Melanin content was not measured until day 14, when it was reduced from 80 5 to 40 & 3 ng/pg protein. Continued culturing of melanocytes in the presence of PDBu for 2-3 months caused further reduction in total melanin content, from the initial level of 80 f 5 to 20 f 2 ng/pg protein.

Because PKC has been implicated in growth control (3-6) and its depletion has been reported to increase proliferation in mouse melanocytes (36), depletion of PKC in human melanocytes might be expected to change the growth rate of these cells and thus indirectly reduce melanogenesis and/or melanin content per cell through dilution. To determine whether PKC depletion changes growth rate in these cells, growth curves were generated for paired untreated and PDBu- treated melanocytes for up to 2 weeks (Fig. 2C). The growth rate was unaffected, excluding the possibility that the de- creased tyrosinase activity and melanin content are secondary to altered growth rate in human melanocytes.

Recovery of Tyrosinase Activity after Regeneration of PKC Activity-If melanin synthesis is dependent on PKC activity, then melanogenic activity should return upon regeneration of PKC. Melanocytes were depleted of PKC by treating with

PDBu and some cultures were then provided with fresh medium lacking PDBu for the final week to regenerate PKC. PKC activity returned to control levels (Fig. 3A), as did tyrosinase activity (Fig. 3B).

Expression of Specific PKC Isoforms in Melanocytes-Be- cause it has been postulated that each isoform of PKC has a unique biological function, we examined which isoforms are expressed in cultured melanocytes. Total RNA was isolated and northern blot analysis was performed using cDNA probes specific for the a, /3, and y isoforms of PKC. Transcripts of both (Y and p isoforms, 9.5 and 4.3 kb for a and 10 and 4.2 kb for /3, as previously reported (37), were expressed (Fig. 4), but the y isoform was not detectable (data not shown). To determine if one of the isoforms is preferentially involved in melanogenesis, melanocytes derived from black and white donors were cultured, and Western blot analysis was performed. Melanocytes from the black donor showed a far higher level of PKC-/3 (Fig. 5, AI ), and melanin contents in paired cultures were 70 and 18 ng/pg protein (Fig. 5, A2) in the black and white cultures, respectively. When melanocytes from three donors with similar pigment content (30-40 ng/pg protein) (Fig. 5, B2) were compared by Western blot analysis in a separate experiment, their level of /3 isoform was similar (Fig. 5, Bl) . These results strongly suggest that the PKC-0 protein level correlates closely with cellular ability to produce melanin.

Correlation of PKC Activity, PKC Isoform Expression, and Melanin Content in a Human Melanoma Line-To further explore the role of the PKC-/3 isoform in human melanogenesis, we employed a model system developed in our laboratory in which pigment level can be varied dramatically. When maintained under its standard culture conditions, the MM4 human melanoma line is moderately pigmented (P-”4) (22). However, when passed weekly to maintain exponential growth, versus once every 3-4 weeks, pigment content de- creases markedly. In at least one subculture, this loss of pigment was irreversible in that if the resulting amelanotic cells were then passed every 3-4 weeks, pigment production did not resume. Instead, the total melanin content and tyrosinase activity are undetectable, (5 ng/pg protein and t 5 0 cpm/pg/h, respectively, in the nonpigmented MM4 (NP- “4) cells, whereas the parent P-MM4 cells maintained under identical conditions contain 40-50 ng/pg protein of melanin and >6,000 cpm/pg/h tyrosinase activity (Fig. 6A).

PKC-p in Human Melanogenesis 11745

FIG. 2. Effect of PDBu treatment on melanocyte PKC activity, tyrosinase activity, and growth rate. Pri- mary cultures of melanocytes from three donors of comparable melanin content (30-40 ng/pg protein) were prepared. At the first passage, 1 X 10' melanocytes were plated in paired 60-mm dishes and treated with 5 X M PDBu or vehicle for 30 min, 2 and 4 h, and up to 3 days. At each interval, duplicate dishes in each group were harvested, cytosol and membrane fraction prepared, and PKC partially purified using DEAE resin and as- sayed for PKC activity (A). From the paired culture dishes, cells were harvested, and 5 pug of total cellular lysate protein were analyzed for tyrosinase activity ( B ) . C, paired primary cultures of melanocytes from the same donors as in (A) were plated onto 60-mm dishes (1 X IO6 cell/plate). At each interval, duplicate dishes from each donor were harvested, and cell number was determined by using the Coulter electronic particle counter. As previously noted (21), plat- ing efficiency of melanocytes was 50- 60%, and there was no significant increase in cell yield above seeding by day 3 when the first cell count was determined. Thereafter, there was good growth as previously noted in this medium (22), comparable in the two groups. Cell numbers, averaged among the three donors, were within 5% of each other a t each time point.

- A.

I Cytosol

Membrane

0 .S 7 .I

Time (Hoursi

6000

T

a

n. " T

Control PKC PKC Depleted Repleted

Conlrol PKC PKC Depleled Repleled

FIG. 3. Regeneration of PKC activity correlates with restoration of tyrosinase activity. Paired cultures of melanocytes were plated and maintained for 3 weeks in standard medium supplemented with vehicle only (Control) or with 5 X lo" M PDBu (PKC Depleted) or after depletion of PKC by treatment with PDBu for 2 weeks, maintained the 3rd week in standard medium alone (PKC Repleted). The activity of PKC (A) and tyrosinase ( B ) was measured in each group at the end of the 3rd week, as described under "Experimental Procedures." Cell numbers in each group at the end of the 3rd week were similar (6 X lo5 -+ 500).

The comparability of growth rates for P-MM4 and NP-MM4 470 uersus 360 cpm/Fg protein. The specific expression of the cells was confirmed over 14 days (Fig. 6B) , excluding the a, p, and y isoforms was then examined for both cell lines. As possibility that the difference in their pigmentation level is expected, the y isoform was not expressed in either P-MM4 due to differences in growth rate. or NP-MM4 cells (data not shown). PKC-a mRNA was

Total activatable PKC level was measured in both the P- expressed in both P-MM4 and NP-MM4 cells but the level MM4 and NP-MM4 melanoma lines. Unlike the earlier ex- was higher in NP-MM4 cells. PKC-8 mRNA was detected periment using normal melanocytes, in which total PKC only in P-MM4 cells (Fig. 6C). Total level of expression, the activity closely correlated with melanin content, PKC activity sum of both a and p isoforms, is comparable in both lines, in P-MM4 cells was only 30% higher than in NP-MM4 cells, consistent with the similar PKC activity observed. These data

11746 PKC-p in Human Melanogenesis

further suggest that the level of PKC-P expression is a major determinant of melanogenesis rate.

Activation of Tyrosinase in NP-MM4 Cells-To determine if lack of PKC-8 expression is responsible for the loss of pigmentation in NP-MM4 cells, initially the levels of tyrosinase protein were determined in NP-MM4 and P-MM4 cells

Alpha Beta -.

PKC

GAPDH "

FIG. 4. Northern blot analysis of PKC isoforms expression in melanocytes. 20 pg of total RNA/lane were fractionated in 1% agarose gel containing 2.2 M formaldehyde, transferred to Hybond-N nylon membrane cross-linked by ultraviolet light illumination, and then each lane was cut, and probed with cDNA specific for PKC-CY and PKC-@. Equal counts of each probe was used for hybridization. Two transcripts of PKC-a (9.5 and 4.3 kb) and two transcripts of PKC-@ (10 and 4.2 kb) were detected as previously reported (35). The contitutively expressed glyceraldehyde-3-phosphate dehydrogenase (GAPDH) serves as a control for even loading of RNA.

Donors While Black

A I .

1 I . I Kl) *

0 White w Black

using Western blot analysis and a polyclonal antibody. NP- MM4 and P-MM4 showed equal amounts of tyrosinase protein (Fig. 7 ) . This result suggested that NP-MM4 cells either lack a factor activating tyrosinase or the tyrosinase enzyme itself has a mutation causing the enzyme to become inactive. To distinguish between these possibilities, NP-MM4 and melanocyte lysates were incubated separately and together for 1 h a t 37 "C, and subsequently tyrosinase activity was measured in each. As expected, the NP-MM4 cell lysate showed undetectable levels of tyrosinase activity, while the melanocyte lysate showed tyrosinase activity of 2,500 cpm/ pg/h. When the melanocyte lysate was mixed with the NP- MM4 lysate, tyrosinase activity expressed as counts/min/pg melanocyte protein more than doubled (Fig. 8A). In a separate experiment using a different melanocyte donor line, tyrosinase activity in the NP-MM4 lysate was again undetectable and that in the melanocyte lysate was approximately 6,000 cpm/pg protein/h (Fig. 8B, lane 2). Immunoprecipitation of the melanocyte lysate with an antibody against PKC-@ prior to mixing with the NP-MM4 lysate completely eliminated the previously observed increase in tyrosinase activity per pg melanocyte protein (lane 3 ) , indicating loss of the factor in the melanocyte lysate responsible for activating tyrosinase in the NP-MM4 lysate. Immunoprecipitation of the melanocyte lysate with anti-P-tubulin antibody, as a control, did not have this effect (lane 4 ) . These results indicate that PKC-/3 activates tyrosinase and that this activation of tyrosinase persists for a t least 2 h, the duration of the experiment, after removal

Transfection of PKC-@ cDNA into NP-MM4 Cells-To of PKC-P.

B1. Dvnvrs

1 2 3 114 KD +

n

FIG. 5. Relationship between PKC-8 protein levels and melanin content in melanocytes. A I , 70 pg of lysate partially purified for PKC, using DEAE-resin, from melanocytes of representative white and black donors were subjected to 7.5% sodium dodecyl sulfate- polyacrylamide gel electrophoresis and Western blot was performed using a monoclonal antibody against PKC-@. A band at the expected molecular mass of 80 kDa is seen in both donor lanes but is far darker in the black donor lane. A2, melanin content in paired cultures of the same donors was determined and was greater in the black donor, as expected. B I , 50 pg per lane of lysate partially purified for PKC from three different donors were analyzed for the level of PKC-@ using the monoclonal antibody against PKC-0. 82, In paired dishes, the total melanin content was measured. Both PKC-@ protein levels and melanin contents are comparable among the three donors.

PKC-/3 in Human Melanogenesis 11747

7 A.

10 B.

P-MM4 NP-MM4

P-MM4 NP-MM4 5 10 15 Days in Culture

PKC-Alpha PKC-Beta

FIG. 6. Comparison of tyrosinam activities, growth rates, and PKC isoform expreeeion in P"M4 and NP"M4 cells. A, P- MM4 and NP-MM4 cells were plated into duplicate 35-mm dishes (0.5 X l@/dish) and when cells were near confluency, tyrosinase activity was measured. B, P-MM4 and NP-MM4,0.5 X 10' cells per 35-mm dishes, were plated and harvested in duplicates at days 4,6,8, 10, 12, and 15. Cell numbers were determined using a Coulter electronic particle counter. C, three sets of Northern analyses, each set consisting of 20 pg of total RNA/lane from NP-MM4 and P-MM4 cells, were performed for the expression of PKC-CY, -8, and -7. Equal counts of each probe was used for hybridization. No hybridization was observed with the PKC--y probe (data not shown). PKC-CY mRNA transcripts (9.5 and 4.3 kb) are easily detected in both cultures (lanes 1 and 2 ) , but PKC-P mRNA transcripts are detectable only in P-"4, but not NP-MM4 cells (lanes 3 and 4 ) . glyceraldehyde-3-phosphate dehydrogenase (GAPDH) probe hybridization was used to confirm even loading of RNA in both blots.

84Kd +

50Kd +

35Kd e

FIG. 7. Level of tyrosinase protein in NP-MM4 and P-MM4 cells. 2.5 X lo6 NP-MM4 and P-MM4 cells were briefly sonicated in 80 mM phosphate buffer (pH 6.8), extracted for tyrosinase at 4 "C for 60 min, and analyzed for the level of tyrosinase protein using a polyclonal antibody as described under "Experimental Procedures."

further confirm that it is PKC-8 activating tyrosinase, NP- MM4 cells were transiently transfected with PKC-P cDNA. After 48-72 h, cells transfected with control cDNA mutated, and inactive PKC showed no tyrosinase activity while cells transfected with PKC-8 showed an activity of 270 It 30 cpm/ pg/h (two independent experiments), indicating that PKC-8 activates tyrosinase in NP-MM4 cells.

DISCUSSION

We present data showing that the 6 isoform of PKC regulates human melanogenesis through activation of tyrosinase. Total activatable PKC roughly correlates with melanin content in cultured melanocytes; and the activation of PKC increases tyrosinase activity, which directly determines melanin production (35), while depletion of PKC by PDBu treatment rapidly reduces tyrosinase activity, and recovery of PKC activity after withdrawal of PDBu conversely leads to nor-

1 1 . 1 4

FIG. 8. Activation of tyrosinase by PKC-8 in NP-MM4 cells. A, lysates for measurement of tyrosinase activity were prepared from NP-MM4 cells and melanocytes. NP-MM4 and melanocyte lysates were incubated separately and together for 60 min at 37 "C and subsequently tyrosinase activity was determined in each. Tyrosinase activity in lysates containing melanocyte protein are expressed as counts/min/pg melanocyte protein/h. When expressed as counts/ min/pg total protein/h, tyrosinase activity was 2,600 in the mixed lysate uersus 2,500 in the melanocyte lysate, indicating both NP- MM4 and melanocyte lysates contain comparable amounts of activatable tyrosinase. B, PKC-j3 was immunoprecipitated from melanocyte lysates to determine the effect on tyrosinase activity or j3- tubulin as a control. Tyrosinase activity was measured in lysates of NP-MM4 cells alone ( l a n e 1 ), melanocytes alone ( l a n e 2 ) , NP-MM4 cells, plus melanocytes after removal of PKC-j3 ( l a n e 31, and NP- MM4 cells plus melanocytes after removal of &tubulin, as a control ( l a n e 4 ) . The increase in tyrosinase activity (approximately 3,000 cmp/pg protein) was similar to that observed in the first experiment ( A ) , suggesting a constant amount of activatable tyrosinase per pg of protein in the NP-MM4 line.

malization of tyrosinase activity and melanin content within 1 week.

Data specifically demonstrating the role of PKC-8 in human pigmentation were obtained with both melanocytes and melanoma cells. In white uersus black donor cultures differing 4-fold in melanin content, PKC-a was comparably expressed

11 748 PKC-B in Human Melanogenesis

at the mRNA and protein levels, while black donor cultures expressed far more PKC-j3 than did the more lightly pigmented white donor cultures. The MM4 melanoma line and its amelanotic subclone NP-MM4 differ by 30% in total activatable PKC, but only the pigmented parental line ex- presses detectable levels of PKC-j3. A factor in melanocyte lysate causing the activation of tyrosinase in NP”M4 lysates was identified as PKC-/3 by immunoprecipitation experiments, and PKC-P activation of tyrosinase was further shown by transient transfection experiments.

The near total (95%) loss of PKC activity in PDBu-treated melanocytes does not cause a proportionate loss of tyrosinase activity. Instead, 32% of tyrosinase activity remained after 2 weeks and 20% after 2 months. However, it is possible that other intracellular pathways may be activated to compensate for the loss of PKC or that the remaining 5% of PKC is capable of sustaining a disportionate percentage of tyrosinase activity.

In retrospect, a possible role of PKC in human melanogenesis was suggested by the first report of cultured human melanocytes. Eisinger and Marko (38) reported that melanocytes grown in presence of 12-O-tetradecanoylphorbol-13- acetate (TPA) had a smaller number of melanosomes, the organelle in which melanogenesis occurs in the cytoplasm, when compared to cells grown in the absence of TPA. More recently, our laboratory showed that 1-oleoyl-2-acetylglycerol, an active analog of diacylglycerol, induces melanogenesis in cultured human melanocytes, while an inactive analog inca- pable of stimulating PKC fails to induce melanogenesis. This effect of 1-oleoyl-2-acetylglycerol was blocked by PKC inhib- itors (20). Melanogenesis stimulated by ultraviolet light, a major physiological inducer of melanogenesis, is also aug- mented by the same diacylglycerol analog in both human melanocytes and S91 Cloudman mouse melanoma cells (39). In B16 mouse melanoma cells, depletion of PKC causes loss of cells’ ability to pigment (40). Furthermore, leukotriene B4- induced human melanogenesis is blocked by the PKC inhib- itor H7 (41). In apparent contradiction to these findings, Halaban and co-workers (35) reported that melanocytes grown in the presence of TPA for 5 months had twice the tyrosinase activity as paired cultures of cells from which TPA had been omitted for 5 days. However, in this report, it was not determined whether PKC was regenerated within 5 days. Moreover, since melanocyte survival depends on the presence of TPA in this culture system (38), as opposed to the TPA- independent system utilized in the present studies, the physiologic condition of these cultures may have precluded normal melanogenesis.

There are number of possible mechanisms for PKC-j3 regulation of melanogenesis. Because melanin content is char- acteristically inversely related to proliferation rate in human melanocytes (42) and because PKC has been implicated in growth regulation of several cell types (3-6), PKC-j3 might regulate melanogenesis indirectly through regulating the rate of cell proliferation. However, our finding that P-MM4 uersw and NP-MM4 cells and PDBu-treated uersw control melanocytes have identical growth rates but strikingly different PKC-j3 levels and melanin contents indicates the regulation of melanogenesis by PKC-j3 cannot be secondary to an effect on proliferation. PKC-P has been also implicated in maintain- ing the differentiation state of various cell types (43, 44). Since melanogenesis is a differentiated function of melanocytes, PKC-/3 may affect melanogenesis indirectly by influ- encing the differentiation status of melanocytes. In the absence of other correlated differentiation markers in melanocytes, however, the possibility cannot be tested directly.

Our data suggest a direct activation of tyrosinase by PKC- P. Indeed, preliminary studies (not included in the present manuscript) strongly suggest that tyrosinase is phosphoryl- ated when melanocytes are treated with TPA (50). In murine melanoma cells, it is known that tyrosinase activity is largely regulated at the post-translational level in that agents induc- ing melanogenesis activate a preexisting pool of tyrosinase enzyme (45), consistent with phosphorylation as the mecha- nism for activation of human tyrosinase.

Previous studies to elucidate the signal transduction pathways controlling melanogenesis, work conducted primarily but not exclusively with mouse melanoma lines, have focused on the role of CAMP. Several agents that elevate intracellular cAMP levels, such as a-melanocyte stimulating hormone, isobutylmethylxanthine and dibutyryl cAMP are known to induce pigmentation, the latter two agents in human melanocytes as well as in murine cells (reviewed in Ref. 46). How- ever, ultraviolet light-induced pigmentation is not accom- panied by an increased intracellular level of cAMP in either human melanocytes or mouse melanoma cells (39), suggesting alternative pathway(s) for pigmentation, at least in response to this physiologic stimulus. Indeed, even pigmentation induced by a-melanocyte stimulating hormone in murine melanoma cells can be blocked by depletion of PKC (47), suggesting CAMP-dependent and PKC-dependent pathways may interact (48,49) in melanin synthesis.

Thus, the present report greatly expands our understanding of the controls for melanogenesis, as well as the role of specific PKC isoforms in mediating specific differentiated functions.

Ackmwkdgements-We thank Dr. U. Stierner (Gotenborg, Swe- den) for providing MM4 human melanoma line, Dr. B. Kwon (Guthrie Research Institute, Sayre, PA) for providing human tyrosinase cDNA (Pmel 34), Dr. Vincent Hearing (National Cancer Institute) for providing polyclonal antibody against tyrosinase, and Judith Fisher for technical assistance.

REFERENCES

2. Nishizuka, Y. (1984) Science 225,1365-1370 1. Bell, R. M. (1986) Cell 45,631-632

3. Whitfield, J. F., Durkin, J. P., Franks, D. J., Kleine, L. P., Raptis, L.,

Reu. 5,205-250 Rixon, R. H., Sikorska, M., and Walker, P. R. (1987) Cancer Metastasis

4. Persons, D. A., Wilkison. W. O., Bell, R. M., and Finn, 0. J. (1988) Cell

5. Housey, G. M., Johnson M. D., Hsiao, W. L. W., O’Brian, C. A,, Murphy, 52,447-458

6. Hsiao, W. L. W., Housey, G. M. Johnson, M. D., and Weinstein, I. B. J. P., Kirschmeier, P., and Weinstein, I. B. (1988) Cell 52,343-354

7. Fisch, T. M., Prywes, R., and Roeder, R. G. (1987) Mol. Cell. Bwl. 7,3490- (1989) Mol. Cell. Bid. 9, 2641-2647

3502 8. Kelly, K., Cochran, B. H., Stiles, C. D., and Leder, P. (1983) Cell 3 5 , 603-

9. Greenberg, M. E., and Ziff, E. B. (1984) Nature 311,433-438 610

10. Hunter, T., Ling, N., and Cooper, J. A. (1984) Nature 311,480-483 11. Bollag, G. E., Roth, R. A., Beaudoin, J., Mochly-Rosen, D., and Koshland,

12. Jeng, A. Y., Srivastava, S. K., Lacal, J. C., andBlumberg, P. (1967) Biochern.

13. Mochly-Rosen, D., Khaner, H., and Lopez, J. (1991) Proc. Natl. Aead. Sci.

14. Albert. K. A.. Nalrn. A. C.. and Greeneard. P. (1987) Proe. Natl. Acad. Sei.

D. E. (1986) Pm. Natl. Aead. Sei. U. S. A. 83,5822-5824

Bwphys. Res. Cornrnun. 146.782-788

U. S. A. 88,3997-4000

U. S . A. 84,704617050 ’ - I

15. Nishizuka. Y. (1992) Science 258.607-614 16. NishiAka; Y . (i9Gj Nature 334,’661-665 17. Pfeffer, L. M., Eisenkraft, B. L., Reich, N. C., Improta, T., Baxter, G:,

Daniel-Issakani, S.. and Strulovici. B. (1991) Proc. Natl. Acad. Set. U. S. A. 8 8 , 7988-7992

Natl. Acad. Scc. U. S. A. 88,598-602

. .

18. Pai, J-K., Pacher, J. A., Weinstein, I. B., and Bishop, W. R. (1991) Proc.

19. Choi. P. M.. Tchou-Wone. K.-M.. and Weinstein. I. B. (1990) Mol. Cell. Bib1 10,4650l4657

7n9

o1 . .

20. Gordon, P. R., and Gilchrest, B. A. (1989) J. Inuest. Dermatol. 9 3 , 700-

21. Giicyrest, B. A. Vrabel, M. A., Flynn, E., and Szabo, G. (1984) J. Inuest.

22. Naeyaert, J. M., Eller, M., Gordon, P. R., Park, H.-Y., and Gilchrest, B. A.

23. Bradford, M. M. (1976) Anal. Biochern. 72,248-254 24. Chirewin. J. M.. Przvbvla. A. E.. MacDonald. R. J.. and Rutter. W. (1979)

Dermatol. 83,370-376

(1991) Br. J. Derrnatol. 125,297-303

B&hemistw,’ 18,-5594-5299 ’ , ,

25. Park, H. Y., and Campisi, J . (1990) Cancer Res. 60,7145-7152

26.

27.

28.

29. 30. 31.

32.

33. 34.

35.

36.

31.

PKC-@ in Human Melanogenesis 11 749 Kwon, B. S., Wakulchik, M., Haq, A. K., Halaban, R., and Kestler, D.

Tso, J . Y., Sun, X-H, Kao, T-h., Reece, K. S., and Wu, R. (1985) Nucleic

Jimenez, M., Maloy, W. L., and Hearing, V. J. (1989) J. BWL Chem. 264,

Laemmli, U. K. (1970) Nature 227,680-685 Pomerantz, S. H. (1966) J . BWL Chem. 241,161-168 Ohno, S., Kawasaki, H., Imajoh, S., and Suzuki, K. (1987) Nature 326,

McCaiYrey, P. G., Friedman, B., and Rosner, M. R. (1984) J. BWL Chem.

Ballester, R., and Rosen, 0. M. (1985) J . Bid. Chern. 260,15194-15199 Blackshear, P. J., Witters, L. A., G i r d , P. R., Kuo, J. F., and Quamo, S.

Halaban, R., Pomerantz, S. H., Marshall, S., Lambert, D. T., and Lerner,

Brooks, G., Wilson, R. E., Dooley, T. P., Goss, M. W., and Hart, I. R.

Yamanishi, D. T., Graham, M., Buckmeier, J. A., and Meyskens, F. L., Jr.

(1988) Biochem. Biophys. Res. Comrnun 163,1301-1309

Acids Res. 13,2485-2502

3397-3403

161-166

269,12502-12507

N. (1985) J . Biol Chem. 260,13304-13315

A. B. (1983) J. CeU. Biol. 97,480-488

(1991) Cancer Res. 61,3281-3288

(1991) Carcinogenesis 12, 105-109

38. Eisinger, H., and Marko, 0. (1982) Proc. Natl. Acad. Sci. U. 5'. A. 79,2018-

39. Friedmann, P. S., Wren, F. E., and Matthews, J. N. S. (1990) J. CeU.

40. Niles R. M and Loe B. P. (1989) Cancer Res. 49,4483-4487 41. Morehi, J. G., H a k e , y S., Murphy, R. C., and Norris, D. A. (1992) J.

42. Friedmann, P. S., and Gilcbrest, B. A. (1987) J. CeU. Physiol. 133,88-94 43. Wooten, M. W., Seibenhener, M. L., Soh, Y., Ewald, S. J., White, K. R.,

Lloyd, E. D., Olivier, A., and Parker, P. J. (1992) FEBS Lett. 298, 74-

2022

Physiol. 142,334-341

Invest. Dermatol. 98, 55-58

7Q

44. Ue% H., Ishida Y., and Taniguchi, H. (1991) FEES Lett. 292,574 45. Won6 G. and $awelek J. (1975) Nature 266,644-646 46. Hean; 9 J and Tsukamoto, K. (1991) FASEB J . 6,2902-2909 47. Park, &U.; Rhssakovsky, V., and Gilchrest, B. A. (1992) Jlnvest. Dermatol.

OLI KC9

48. Cambier, J. C., Newell, M. K., Justemenl

49. Yoshimasa, T., Slbley L., and Chen, Z. Z.

50. Park, H.-Y., Russako. G. (1987) Nature 3:

vu, -"I

Clin. Res., in press

JOURNAL OF Vol. 268, No. 16, of June 5, pp. 11742-11749 ... · THE JOURNAL OF BIOLOGICAL CHEMISTRY 0 1993 by The American Society for Biochemistry and Molecular Biology, Inc Vol.

Documents